Biofilm-producing bacteria linked to wound infections pose a significant clinical challenge due to their exceptional resistance to drugs. This resistance contributes to increased morbidity, adverse outcomes such as delayed healing, and escalated healthcare costs. Bacterial wound infections, with an intensifying prevalence of multi-drug resistant bacteria, necessitate the formulating of evidence-based decision-making processes, particularly in resource-limited…